During the past 15 years, breakthrough discoveries have revolutionized the treatment landscape for most patients with lung cancer, progress that has helped fuel an overall drop in cancer mortality.
Andrew Smith
Advertisement
Articles by Andrew Smith
Advertisement
Latest Updated Articles
Progress on New Therapies Stirs Hope in SCLCPublished: September 15th 2022 | Updated:
New Treatments Offer Hope for Patients With TNBCPublished: March 13th 2017 | Updated:
Putting in Longer Hours for World-Class CarePublished: July 11th 2016 | Updated:
Flat Fee Plan Boosts Outcomes and PayPublished: October 12th 2016 | Updated:
Insured Patients Flock to Mobile ClinicPublished: November 24th 2016 | Updated:
A Preemptive Leap to Patient-Centered CarePublished: January 18th 2017 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
5